December 29, 2024 - 13:30

As the year draws to a close, investors are hopeful for a rebound in the stock market after a lackluster start to the anticipated "Santa Claus" rally. Historically, this period has been characterized by positive market trends, but recent fluctuations have raised concerns among traders.
In the final stretch of 2024, market participants are closely monitoring key economic indicators and corporate earnings reports that could influence stock performance. Analysts suggest that a combination of seasonal buying and optimism surrounding holiday spending may provide the necessary momentum for a year-end rally.
However, uncertainties remain, including potential interest rate changes and geopolitical tensions that could impact market sentiment. Investors are advised to stay vigilant and consider diversifying their portfolios to navigate these unpredictable conditions. As the trading week progresses, all eyes will be on how market dynamics unfold and whether stocks can recover in time for a strong finish to the year.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...